COMPANY PROFILE

Belhaven Bio

Leveraging its expertise in drug development and formulation with its patented technology to expand patient access to life saving medications

Raleigh, United StatesFounded 2021Biotech & Life Sciences

Valuation $100–250M Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Belhaven Bio

Belhaven Biopharma, founded in 2021 in Raleigh, North Carolina, focuses on developing novel dry powder formulations for the rapid and painless delivery of lifesaving medications. The company primarily targets patients who require immediate treatment for life-threatening allergic reactions, such as anaphylaxis. Operating in the biopharmaceutical sector, Belhaven collaborates with industry partners and government entities to commercialize its drugs. The business model revolves around research and development, transitioning from initial formulation work to clinical development, and expanding its product portfolio. Revenue is generated through partnerships, government collaborations, and eventual drug sales. Belhaven's core competencies include bioequivalence regulatory pathways and innovative drug delivery systems.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2021
Headquarters: Raleigh, United States
Employees: 14
Open positions: None listed
Dealroom signal: 78.2/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Oct 2025	$32M	$129M	Undisclosed	↗
SEED✓Equity / VC	Jan 2025	$11M	$44M	Hatteras Venture Partners	—

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Belhaven Bio website traffic

Latest recorded traffic for Belhaven Bio is 1.3K monthly website visits, down 53.6% over the last three months. Belhaven Bio's team grew 16.7% over the past year.

Latest monthly visits1.3K 3-month web change-53.6% 1-year team growth+16.7%

Monthly website visitsJun 2024–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
PBProxima BioFormerly VantAI. Proximity therapeutics hijacking cellular machinery for protein degradation	New York City, United States	Operational	77	$80M	$320M
KAKolate AIAdvanced analytics platform accelerating drug development with real-time insights and competitor monitoring	Montgomery Township, United States	Operational
SASanegeneBioDeveloping targeted RNAi-based medicines for obesity, cardiometabolic and autoimmune diseases	Woburn, United States	Operational
PBPattern BiosciencesBuilds biomolecular computers that run molecular programs in cells to treat cancer and other diseases	South San Francisco, United States	Operational
BIBioOrbitBioOrbit is space manufacturing company developing hardware for the large-scale crystallisation of protein drugs	London, United Kingdom	Operational
SMSuperluminal MedicinesGenerative biology and chemistry company revolutionizing the speed and accuracy of how medicine is created	Boston, United States	Operational
PHPhaseVUses advanced algorithms to optimize clinical trials, improving success rates, efficiency, and uncovering hidden signals in the data	Tel Aviv-Yafo, Israel	Operational
NBNew BiologixEngineered cell line technology that produces safe and effective AAV drugs for gene therapy, making treatments more affordable and accessible	Epalinges, Switzerland	Operational